<html>
<head>PUBMED IDs for TKC</head>
<body bgcolor='#C5F0F2'><h1>TKC</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2284000/'>Negative and positive transcriptional regulation by thyroid hormone receptor isoforms.</a> October 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/2040690/'>Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.</a> June 1  1991<br><a href='https://pubmed.ncbi.nlm.nih.gov/8453994/'>Activation of gene expression via CArG boxes during myogenic differentiation.</a> March 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/7945936/'>A TEF-1 binding motif that interacts with a placental protein is important for the transcriptional activity of the hCS-B enhancer.</a> October 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8858571/'>The effect of matrix attached regions (MAR) and specialized chromatin structure (SCS) on the expression of gene constructs in cultured cells and in transgenic mice.</a> January 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8858571/'>The effect of matrix attached regions (MAR) and specialized chromatin structure (SCS) on the expression of gene constructs in cultured cells and in transgenic mice.</a> January 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9299613/'>P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.</a> September 23  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9419421/'>Positive and negative regulation of the human thymidine kinase promoter mediated by CCAAT binding transcription factors NF-Y/CBF, dbpA, and CDP/cut.</a> January 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11038283/'>Human ras-converting enzyme (hRCE1) endoproteolytic activity on K-ras-derived peptides.</a> October 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/16772425/'>Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis.</a> June 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/23861345/'>BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.</a> April 2  2013<br></body></html>
